EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
NCT ID: NCT02209415
Last Updated: 2014-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
182 participants
INTERVENTIONAL
2011-04-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is because the methods and the consequence of following these patients is unknown.
Therefore the investigators will randomize these patients in to two groups:
1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.
2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Preoperative Investigations in Patients With Liver Cancer
NCT00408122
Evaluation of PET and Laparoscopy in STagIng Advanced Gastric Cancer
NCT03208621
EUS vs. MDCT in Pancreatic Malignancy
NCT02115022
Micrometastasis in Gastrointestinal Cancer
NCT01919151
Image Fusion PET, CT and 3D-ultrasound Examinations
NCT00302094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard outpatient follow-up
Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery
standard follow-up
Outpatient clinic visits
Intervention PET/CT and EUS
PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery
PET/CT and EUS
PET/CT and EUS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard follow-up
Outpatient clinic visits
PET/CT and EUS
PET/CT and EUS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Michael Bau Mortensen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Bau Mortensen
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Surgical Ultrasound, Department of upper surgical gastroenterology
Odense, Region Syddanmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bjerring OS, Fristrup CW, Pfeiffer P, Lundell L, Mortensen MB. Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study). Br J Surg. 2019 Dec;106(13):1761-1768. doi: 10.1002/bjs.11290. Epub 2019 Oct 9.
Bjerring OS, Hess S, Fristrup CW, Hoilund-Carlsen PF, Mortensen MB. The impact of endoscopic ultrasound-guided fine-needle aspiration of lymph nodes on subsequent positron emission tomography/computed tomography imaging: a prospective study. Endoscopy. 2019 Feb;51(2):165-168. doi: 10.1055/a-0647-6824. Epub 2018 Jul 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-41-5702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.